Lee Jarm

Lee Jarm has over 25 years of experience in market insights and research across various pharmaceutical and healthcare organizations. Currently serving in the Plasma Derived Therapies Business Unit at Takeda since December 2021, Lee previously held roles at Deciphera Pharmaceuticals, Biogen, and Medtronic, focusing on global customer and market insights, competitive landscape assessment, and health informatics. Prior roles include positions at Blue Cross Blue Shield of Massachusetts, Health Dialog, and Merck & Co., where Lee managed comprehensive market research projects and contributed to strategic initiatives in neuroscience and specialty sales. Lee holds an MBA in International Business from the Isenberg School of Management at UMass Amherst and has additional education in Public Health and International Relations.